| 000 | 00959 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513040341.0 | ||
| 264 | 0 | _c19930727 | |
| 008 | 199307s 0 0 eng d | ||
| 022 | _a0017-5749 | ||
| 024 | 7 |
_a10.1136/gut.34.2_suppl.s74 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDianzani, F | |
| 245 | 0 | 0 |
_aBiological basis for the clinical use of interferon. _h[electronic resource] |
| 260 |
_bGut _c1993 |
||
| 300 |
_aS74-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aHepatitis B _xtherapy |
| 650 | 0 | 4 |
_aHepatitis C _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferons _xtherapeutic use |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aVirus Diseases _xtherapy |
| 773 | 0 |
_tGut _gvol. 34 _gno. 2 Suppl _gp. S74-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.34.2_suppl.s74 _zAvailable from publisher's website |
| 999 |
_c7685546 _d7685546 |
||